MYEOV and cancer: It might actively contribute to oncogenic processes through DNA amplifications or chromosomal translocations of this locus containing both CCND1 and MYEOV-3′-putative enhancer (Janssen et al., 2002b; Zhou et al., 2022), potentially allowing it to influence the expression levels of other proto-oncogenes (in addition to CCND1) that may end up in the proximity of the amplified copies, thereby expanding its impact on the dynamics of cellular function in cancer.